All terms in BAO
| Label | Id | Description |
|---|---|---|
| Borjeson-Forssman-Lehmann syndrome | DOID_0050681 | [An X-linked disease that is characterized by intellectual disability, truncal obesity, seizures, hypogonadism, developmental delay, distinctive facial features, tapered fingers and short toes and has_material_basis_in X-linked recessive inheritance of mutations in the PHF6 gene.] |
| Boomerang dysplasia | DOID_0050680 | |
| small cell carcinoma | DOID_0050685 | [A carcinoma that is an undifferentiated neoplasm composed of primitive-appearing cells.] |
| Bowen-Conradi syndrome | DOID_0050684 | |
| meningoencephalitis | DOID_10554 | [A central nervous system disease that involves encephalitis which occurs along with meningitis.] |
| ureteral benign neoplasm | DOID_11885 | |
| nephrolithiasis | DOID_585 | |
| calcimimetic | CHEBI_48525 | |
| estrogen antagonist | CHEBI_50837 | |
| spin label | CHEBI_35210 | |
| cancer | DOID_162 | [A disease of cellular proliferation that is malignant and primary, characterized by uncontrolled cellular proliferation, local cell invasion and metastasis.] |
| C1 inhibitor deficiency | DOID_0060002 | [A complement deficiency that is a functional deficiency in the complement component C1 inhibitor leading to hereditary angioedema (HAE) involving swelling due to leakage of fluid from blood vessels into connective tissue.] |
| radioactive label | CHEBI_35211 | |
| infective endocarditis | DOID_0060000 | [An endocarditis that is characterized by inflammation of the endocardium caused by infectious agents.] |
| brachydactyly-syndactyly syndrome | DOID_0050689 | |
| EC 3.5.1.19 (nicotinamidase) inhibitor | CHEBI_84264 | |
| acute urate nephropathy | DOID_580 | |
| Aland Island eye disease | DOID_0050630 | |
| tight binding inhibition | BAO_0000490 | [In this type of inhibition, the population of free, soluble inhibitor is significantly depleted by the formation of the enzyme-inhibitor or enzyme-substrate-inhibitor complex. While tight-binding inhibitors can bind to the target enzyme in a competitive, noncompetitive, or uncompetitive manner with respect to substrate binding, they can display noncompetitive phenotypes.] |
| MTP inhibitor | CHEBI_72298 |